Dexcom G7 complete guide 2026
The Dexcom G7 is a leading continuous glucose monitor featuring a 60% smaller all-in-one sensor-transmitter, 10-day wear, and 30-minute warm-up. Here's everything you need to know for 2026.
| Wear Duration | 10 days + 12-hour grace period |
| Warm-Up Time | 30 minutes |
| Accuracy (MARD) | 8.2% |
| Reading Interval | Every 5 minutes |
| Water Resistance | IP28 — 2.4 m for 24 hours |
| Approved Age | 2 years and older |
| Transmitter | Integrated disposable |
| Calibration | Not required |
🔑 Key Takeaways
- The Dexcom G7 combines sensor and transmitter into one disposable unit — no separate transmitter to charge
- 10-day wear period plus a 12-hour grace period (10.5 days total)
- 30-minute warm-up — the fastest of any major CGM in 2026
- 60% smaller than the Dexcom G6
- Compatible with iOS, Android, Apple Watch, and Dexcom's own receiver
- Direct-to-watch readings available without carrying a phone
- FDA-approved for non-adjunctive use (no fingerstick confirmation required for dosing)
What Is the Dexcom G7?
The Dexcom G7 is a real-time continuous glucose monitoring (CGM) system designed for adults and children (aged 2+) with diabetes. It measures interstitial glucose every 5 minutes, delivering readings, trend arrows, and customisable alerts to a connected smartphone or dedicated receiver. Unlike its predecessor the G6, the G7 integrates the sensor and transmitter into a single, fully disposable pod — eliminating the need to manage a separate rechargeable transmitter.
The G7 received FDA clearance in December 2022, CE marking in Europe, and has rapidly become the benchmark CGM for both Type 1 and insulin-using Type 2 diabetes management entering 2026.
Technical Specifications
| Specification | Dexcom G7 |
|---|---|
| Sensor wear duration | 10 days + 12-hour grace period |
| Warm-up time | 30 minutes |
| Reading frequency | Every 5 minutes |
| MARD (accuracy) | 8.2% |
| Transmitter | Integrated (disposable) |
| Water resistance | IP28 — up to 2.4 m for 24 hours |
| Bluetooth range | ~9 metres (30 ft) |
| Approved age range | 2 years and older |
| Calibration required | No (optional) |
| Wear site | Upper arm (adults); abdomen/upper buttocks (paediatric) |
Accuracy: How Reliable Is the G7?
The G7 achieves a Mean Absolute Relative Difference (MARD) of 8.2% against venous blood glucose, making it one of the most accurate CGMs available. In clinical studies, over 92% of readings fell within the clinically acceptable Zone A of the Clarke Error Grid. Accuracy is maintained across the glucose range of 2.2–22.2 mmol/L (40–400 mg/dL).
Importantly, the G7 is FDA-approved as a non-adjunctive device, meaning users can make insulin dosing decisions based on G7 readings alone — no confirmatory fingerstick required.
Setup and Application
- Clean and dry the upper arm insertion site
- Remove the G7 applicator from packaging
- Press the applicator firmly against the skin until it clicks
- Open the Dexcom G7 app and scan the sensor code
- Wait 30 minutes for the warm-up to complete
- Readings begin automatically — no further action needed
The applicator is a one-button design, making it significantly easier to self-apply than many competitors. The smaller footprint also reduces snag risk during daily activities.
Dexcom G7 vs G6: Key Differences
| Feature | G7 | G6 |
|---|---|---|
| Size | 60% smaller | Larger pod + separate transmitter |
| Warm-up | 30 min | 2 hours |
| Transmitter | Disposable (integrated) | Reusable (charge every 10 days) |
| Wear duration | 10 days + grace period | 10 days |
| Direct-to-watch | Yes (iOS & Android) | Limited |
| MARD | 8.2% | 9.0% |
Compatibility and Integrations
- Smartphones: iPhone (iOS 15+) and Android (8.0+)
- Smartwatches: Apple Watch (Series 4+), Wear OS (select models)
- Insulin pumps: Tandem t:slim X2 (Control-IQ), Omnipod 5 (closed-loop compatible)
- Dexcom Clarity: Cloud-based data management and clinician sharing
- Apple Health / Google Health Connect: Supported
- Receiver: Dexcom G7 dedicated receiver (for phone-free use)
Who Should Use the Dexcom G7?
The G7 is suited for:
- Adults and children (2+) with Type 1 diabetes
- Insulin-using Type 2 diabetes patients
- Anyone using a closed-loop insulin delivery system (Omnipod 5, Tandem Control-IQ)
- People who previously found CGM warm-up times or transmitter management inconvenient
If you are managing diabetes and want real-time glucose visibility with the least friction, the Dexcom G7 available from MDS Diabetes is the leading option in 2026.
Practical Tips for Maximising G7 Performance
- Rotate sites: Allow at least 2–3 cm between insertions to prevent skin irritation
- Avoid pressure: Sleeping directly on the sensor can cause compression lows — false low readings
- Stay hydrated: Dehydration can temporarily affect interstitial fluid accuracy
- Use the grace period: Apply your next sensor before the current one expires to minimise gaps
- Adhesive extenders: For active users or swimmers, over-patches can extend adhesion